| Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease EJ Benner, RL Mosley, CJ Destache, TB Lewis, V Jackson-Lewis, ... Proceedings of the National Academy of Sciences 101 (25), 9435-9440, 2004 | 368 | 2004 |
| HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia H Xiong, YC Zeng, T Lewis, J Zheng, Y Persidsky, HE Gendelman Journal of neurovirology 6 (1), S14, 2000 | 110 | 2000 |
| Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease MD Boska, TB Lewis, CJ Destache, EJ Benner, JA Nelson, M Uberti, ... Journal of Neuroscience 25 (7), 1691-1700, 2005 | 84 | 2005 |
| Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring MD Boska, RL Mosley, M Nawab, JA Nelson, M Zelivyanskaya, ... Current HIV research 2 (1), 61-78, 2004 | 45 | 2004 |
| Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy TB Lewis, JN Glasgow, AM Glandon, DT Curiel, DG Standaert PLoS One 5 (9), e12672, 2010 | 23 | 2010 |
| Design of clinical trials of gene therapy in Parkinson disease TB Lewis, DG Standaert Experimental neurology 209 (1), 41-47, 2008 | 22 | 2008 |
| Fiber-modified adenovirus for central nervous system Parkinson’s disease gene therapy TB Lewis, JN Glasgow, AS Harms, DG Standaert, DT Curiel Viruses 6 (8), 3293-3310, 2014 | 19 | 2014 |
| Striatal cholinergic dysregulation after neonatal decrease in X‐linked dystonia parkinsonism‐related TAF1 isoforms MD Cirnaru, J Creus‐Muncunill, S Nelson, TB Lewis, J Watson, ... Movement Disorders 36 (12), 2780-2794, 2021 | 11 | 2021 |
| Parkinson Disease, Primates, and Gene Therapy: Vive la Différence? TB Lewis, DG Standaert Movement disorders: official journal of the Movement Disorder Society 26 (1), 2, 2011 | 9 | 2011 |
| 19‐year‐old male with headaches and a possible seizure MLP Nasrallah, IM Nasrallah, MS Prelack, MO Johnson, TB Lewis, ... Brain Pathology 27 (4), 557, 2017 | 2 | 2017 |
| Development of an adenoviral vector platform for selective gene delivery to neurons TB Lewis The University of Alabama at Birmingham, 2012 | | 2012 |
| Transduction of Dopamine Neurons by Adenoviral Vectors is Modulated by CAR Expression: Rationale for Tropism Modified Vectors in PD Gene Therapy TB Lewis, JN Glasgow, AM Glandon, DT Curiel, DG Standaert MOVEMENT DISORDERS 25, S671-S671, 2010 | | 2010 |
| Coxsackie and Adenovirus Receptor Expression Dictates Neuronal Tropism in the Mouse Substantia Nigra TB Lewis, JN Glasgow, AM Glandon, DG Standaert, DT Curiel MOLECULAR THERAPY 17, S356-S356, 2009 | | 2009 |
| CCR5 chemokine receptor T Lewis, H Gendelman xPharm: The Comprehensive Pharmacology Reference, 1-12, 2007 | | 2007 |
Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical CenterVerified email at unmc.edu
